Make plans to participate in the upcoming PET Drugs Manufacturing Summit to ensure your voice is part of the Coalition’s strategic action plan. Don’t miss this unique opportunity to engage with your peers to develop the Coalition's 5-yr strategy to shape the future regulatory environment for PET drug manufacturing. The Summit is being designed as a peer-led, interactive forum to identify systemic barriers in our field and co-create a unified roadmap for advancing the production of safe and effective PET drugs, thus ensuring patient access to vital diagnostic agents.

The summit will be held November 11-12, 2026, in-person, at Telix Pharmaceuticals’ conference facility in Irving, Texas, with a tentative start time of 8:00 a.m. on Wednesday, November 11 and concluding by mid-afternoon on Thursday, November 12. Coalition leadership chose this facility because of it is close to DFW airport, making it easily accessible to all participants.

Registration costs are still being determined. The Coalition does not intend to make any profit, so fees will be nominal.

Event format:

• After polling the PET drug manufacturing community, the program committee will recruit leaders who will initiate and moderate discussion on what the community has determined are the most important 5-6 topics.

• The summit is an in-person only meeting.

• Day 1: We will devote 60-75 minutes per topic. Each session will include an introduction, substantive discussion, and conclude with a recap of proposed recommendations/next steps.

• Day 2: Will start with a summarization of Day 1 outcomes, and then focus on aligning on prioritization and a strategic action plan.

• Our goal is to unite around these topics and leave the meeting with a summary and a solid draft of a strategic action plan. The summary and plan will be distributed to all members whether they attend or not.

• Only PET drug manufacturers are invited to participate (both Coalition members and non-members). Representatives from the FDA or other regulatory agencies will not be present.

Important Commitments Related to Antitrust and Competition Laws

The purpose of this symposium is to facilitate lawful, pre-competitive collaboration on matters of mutual interest to both academic and commercial members. The Coalition and its participants are fully committed to complying with all applicable antitrust and competition laws.

Participation in this meeting is strictly limited to discussions that are appropriate for an industry coalition and that promote patient access, safety, regulatory compliance, scientific advancement, and other legitimate industry objectives. The meeting will not include, and participants are expressly prohibited from engaging in, any discussion or exchange of competitively sensitive information, including but not limited to pricing, pricing strategies, costs, production levels, market allocation, customer allocation, bid strategies, or other competitively sensitive business decisions. By hosting or attending this meeting, neither the host facility nor any participant assumes responsibility for, or control over, the independent business decisions of other attendees.